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Dynamic prediction incorporates time-dependent marker information accrued during follow-up to
improve personalized survival prediction probabilities. At any follow-up, or “landmark”, time, the
residual time distribution for an individual, conditional on their updated marker values, can be used
to produce a dynamic prediction. To satisfy a consistency condition that links dynamic predictions
at different time points, the residual time distribution must follow from a prediction function that
models the joint distribution of the marker process and time to failure, such as a joint model. To
circumvent the assumptions and computational burden associated with a joint model, approximate
methods for dynamic prediction have been proposed. One such method is landmarking, which fits a
Cox model at a sequence of landmark times, and thus is not a comprehensive probability model of
the marker process and the event time. Considering an illness-death model, we derive the residual time
distribution and demonstrate that the structure of the Cox model baseline hazard and covariate effects
under the landmarking approach do not have simple form.We suggest some extensions of the landmark
Cox model that should provide a better approximation. We compare the performance of the landmark
models with jointmodels using simulation studies and cognitive aging data from the PAQUID study.We
examine the predicted probabilities produced under both methods using data from a prostate cancer
study, where metastatic clinical failure is a time-dependent covariate for predicting death following
radiation therapy.
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1 Introduction
As survival outcomes for patients improve, there is additional follow-up information available and
increased interest in predicting conditional survival for patients at a timebeyonddiagnosis or treatment.
To achieve the most accuracy, prediction models should incorporate patient information that evolves
over time and was collected during follow-up. The statistical task is to develop a technique that can
quantify survival probability predictions at baseline, and produce updated risk predictions at future
time points for patients who are still alive by including their new marker information.
Recent literature has explored obtaining dynamic predictions with the use of joint models for
longitudinally measured markers and time-to-event outcomes (Taylor et al., 2005; Rizopoulos, 2011;
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Taylor et al., 2013; Rizopoulos et al., 2013). Joint modeling requires the specification of a model for
the marker process, a model for the survival outcome, and a method by which to link the two models
(Henderson et al., 2000). This is sufficient to obtain the joint distribution of the marker process and
failure time, from which the residual time distribution can be easily derived at any landmark time of
interest. Computing conditional survival probabilities from this distribution may involve numerical
integration and require substantial computation. Joint models require correct specification of the
joint distribution of the marker process and the event time and can require computationally intensive
techniques for estimation. To avoid making distributional assumptions about the marker process
and to reduce the computational burden, approximate approaches for dynamic prediction have been
developed that specify a model for only a component of the joint distribution of the marker and failure
time processes.
One such approach to dynamic prediction is called “landmarking”. This approach was first intro-
duced in the context of clinical oncology by Anderson et al. (1983) as an alternative to a Cox model
with a time-dependent covariate. In van Houwelingen (2007), the landmarking approach applies a
simple Cox proportional hazards model to the data of individuals still alive at τ , and the resulting
estimates are used to predict the probability of surviving up to a fixed horizon, τ + s. To link the
landmark models, the estimated effects are allowed to change with landmark time in a smooth way.
Since this method can be implemented using the Cox model, and since time is always measured from
the original time origin, estimation can be conducted based on a partial log-likelihood method. Zheng
andHeagerty (2005) proposed a similar approach called “partly conditional survival modeling”, which
describes landmarking in the context of resetting the clock at the landmark time.
The appeal of landmarking is that it avoids specifying the distribution of the stochastic marker
process in time. However, as demonstrated by Jewell and Nielsen (1993), approximate approaches
fail to produce predictions that are consistent (i.e. have a defined relationship) with predictions at
other landmark times. Valid prediction functions require the definition of a model for the stochastic
marker process and the functional relationship between the marker and the hazard at any given time.
The residual time distribution, upon which predictions are based, is determined by the hazard at
w = τ + s, s > 0 conditional on event timeT > τ andmarker processZ(τ ). The consistency condition
proposed by Jewell and Nielsen (1993) states that if the hazard function is determined by Z(t) and
denoted h(t,Z(t)), the hazard at all times w > τ cannot be arbitrarily chosen but must be computed
from h(w|τ,Z(τ )) = E[h(w,Z(w))|T > τ,Z(τ )], where the expectation is with respect to the distribu-
tion of Z between τ and w. Thus, specification of the marker process distribution is necessary to link
the hazards over time to produce consistent predictions. Under the landmarking approach, the model
for h(w|τ,Z(τ )) is chosen to have the form of a Cox regression, which can be easily fit using standard
software. Thus, landmarking produces a sequence of best-fitting Cox models at each landmark time
and there is no restriction on the predictions from each Cox model being consistent with those at
earlier time points. Based on this violation of the consistency rule, an approach for prediction models
that is based on modeling only the residual time may result in theoretically incorrect models.
It is well known that the residual time distribution based on a time-varying marker will depend on
the stochastic process of the marker (Kalbfleisch and Prentice, 2011). Jewell and Kalbfleisch (1996)
provided some specific examples of residual time distributions for additive models. Shi et al. (1996)
showed that if the marker is following a Brownian motion then a reasonable approximation to the
residual time distribution is based on the linear transformationmodel (T − τ )1/3 = g(Z(τ )) + , where
g is amonotonic function and  has a constant variance distribution. In discussing differences between a
time-dependent Cox model and a landmarking approach, Putter and van Houwelingen (2016) showed
that a proportional hazards assumption will not in general be valid for the landmarking model.
Whether the lack of theoretical justification for the landmarking approach is a practical concern may
depend on what landmarking models are used. Extensions in the landmark framework that increase
flexibility may provide a sufficiently good approximation to the true residual time distribution.
The comparison of predictive performance between joint models and landmarking approaches
has been recently explored in the statistical literature. Cortese et al. (2013) compared predictions of
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cumulative incidence between amultistatemodel and landmark approaches under competing risks, and
found that the twomodeling strategies had nearly identical predictive accuracy.Rizopoulos et al. (2013)
demonstrated the superiority of the survival prediction accuracy of a joint model over landmarking
under various functional forms of the association structure between a continuous longitudinal marker
and failure time processes. Maziarz et al. (2016) proposed two models in the partly conditional
modeling framework and compared them to a joint model by simulating data from a shared random-
effects model. They showed that predictions obtained from partly conditional survival models are
comparable to those from a joint model, but that partly conditional models have better computational
efficiency.
We aim to contribute to this literature by contrasting landmark and joint models for dynamic
prediction in the context of a binary longitudinal marker, represented by an illness-death model. In
Section 2, we introduce notation for landmark and joint models and derive their predicted probabil-
ities in the context of the illness-death model. Section 3 demonstrates that the landmark approach
with a standard Cox model does not satisfy the consistency condition of Jewell and Nielsen (1993),
and suggests extensions to provide a better approximation. Section 4 compares the performance of
landmark and joint models using a simulation study. In Section 5, we apply these methods to cognitive
aging data from the PAQUID study and metastatic clinical failure data from a prostate cancer study,
and conclude with a discussion in Section 6.
2 Approaches for dynamic individualized predictions
LetDn = {T ∗i , δi,Xi,Zi; i = 1, . . . , n} denote the observed data, whereTi is the true event time,Ci is the
censoring time, T ∗i = min(Ti,Ci) is the observed event time, δi = 1(Ti ≤ Ci) is the censoring indicator,
Xi is the baseline covariate vector, and Zi is the longitudinal marker vector, with zil = Zi(til ) denoting
the marker value at time til , l = 1, . . . , ni, for subject i.
The aim is to obtain a prediction probability for a new subject, j, from the same population, who
has current marker and baseline covariate data available. Specifically, we are interested in obtaining a
prediction probability of surviving up to time τ + s, s > 0, given that subject j has survived up to time
τ , that is
p j (τ + s|τ ) = Pr(Tj ≥ τ + s|Tj > τ,Dn,X j,Zj (τ )) (1)
where Zj (τ ) denotes the subject’s marker value at time τ . In this probability statement, τ is called
the landmark time and s is the prediction window. The dynamic nature of this prediction probability
lies in its ability to be updated as new information for patient j becomes available at time τ ∗ > τ , to
produce the new prediction p j (τ
∗ + s|τ ∗). Implicit in Eq. (1) is that the value ofZ is known for subject
j at time τ . In practice this may not be the case. An alternative target of interest is to change Eq. (1)
to condition on the known history of Z up to time τ for subject j.
2.1 Joint modeling
Jointmodeling requires the full specification of the joint distribution of the longitudinalmarker process
and the survival data. The joint density is often factored into a product of the densities of Z and T |Z,
which requires specifying the model for the longitudinal marker process and a model for the event
times with dependence on the defined marker process. As shown in Jewell and Kalbfleisch (1992) and
Shi et al. (1996), once these distributions are specified the residual time distribution can be derived.
IfZ is a discrete random variable, joint modeling consists of formulating a process for the transitions
between the states of Z and defining the relationship between the covariate process and survival using
a hazard function for T . This is sufficient to derive the joint distribution of Z and T , from which the
residual time distribution is then determined.
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Figure 1 An irreversible illness-death model depicting three states, 0 (Healthy), 1 (Illness), and 2
(Dead), and the transition intensities between state j and state k (λ jk(t|X)), where X is a vector of
baseline covariates that can have transition-specific effects.
The irreversible illness-death model is the simplest example of discrete Z. In this model, Z is binary
with only two states {0,1}, all subjects start in state 0, and transitions from state 1 to state 0 are not
allowed. Let T be the time to death, which is a terminal state. Then the joint distribution of Z and T
can be described as a simple three-state illness-death model (0: Healthy, 1: Illness, 2: Dead), as shown
in Fig. 1. We then define the time-varying covariate process Z(t) ∈ {0, 1} as an indicator of whether
an individual has progressed from the “healthy” state to the “illness” state by time t. In this model,
λ jk(t|X) describes the hazard of transitioning from state j to state k at time t conditional on the
baseline covariate vector X, which can have a different effect on each transition. We assume that the
clock does not reset once an individual has transitioned into the illness state, and thus t is time since
baseline. As well, we can model the rate of transition to be dependent on the duration in the current
state for those in the ill state. Under the illness-death model, the residual time distribution conditional
on Z(τ ) is:
Pr(T ≥ τ + s|T > τ,X,Z(τ ) = 0) = exp
{
−
∫ τ+s
τ
[
λ02(u|X) + λ01(u|X)
]
du
}
+
∫ τ+s
τ
exp
{
−
∫ v
τ
[
λ02(u|X) + λ01(u|X)
]
du
}
λ01(v|X) exp
{
−
∫ τ+s
v
λ12(u|X) du
}
dv (2)
Pr(T ≥ τ + s|T > τ,X,Z(τ ) = 1) = exp
{
−
∫ τ+s
τ
λ12(u|X) du
}
(3)
In Eq. (2) the first term represents the probability that the individual remained in state 0 from time τ
to τ + s, and the second term is the probability the individual transitioned from state 0 to 1 at time
v ∈ (τ, τ + s) and then remained in state 1 from time v to τ + s.
The observed data is given as Dn = {T ∗i , δi,Xi,Zi,Vi; i = 1, . . . , n}, where in addition to the pre-
viously described notation, Vi is the known, exact transition time from state 0 to state 1 for the ith
individual if they have transitioned. Thus, using a joint model approach, the full likelihood can be
written as
L =
∏
i
exp
[− {1− Zi(T ∗i )} {01(T ∗i |Xi) + 02(T ∗i |Xi)}] λ02(T ∗i |Xi)δi(1−Zi(T ∗i ))
× exp [−Zi(T ∗i ) {01(Vi|Xi) + 02(Vi|Xi)}] λ01(Vi|Xi)Zi(T ∗i )
× exp [−Zi(T ∗i ) {12(T ∗i |Xi) − 12(Vi|Xi)}] λ12(T ∗i |Xi)δiZi(T ∗i )
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where i j (t|X) =
∫ t
0 λi j (u|X) du is the cumulative hazard. Using the likelihood, parameter estimates
of the joint model can be obtained, from which the desired residual time distribution in Eqs. (2) and
(3) are computed. Since it is unlikely that the exact transition times are observed in practice, this
likelihood can be adjusted to accommodate interval-censored observation times (Commenges, 2002).
Alternatively, a semi-Markov model, for which the transition to death from the illness state depends
on the duration in the illness state, can be fit (Foucher et al., 2010).
2.2 Landmarking
Landmarking describes the approach in which models are proposed and estimation is conducted at a
set of prediction times of interest, defined as landmark times. There are several models and estimation
methods that exist within the landmarking framework. After a model is selected and fit, the required
residual time distribution given by Eq. (1) can be calculated.
The idea behind landmarking is to preselect a landmark time, τ , at which there is interest in making
a prediction. Given access to a database of patient information, if we were interested in predicting
survival up to time τ + s for patients still alive at τ , we could select all the patients in the database alive
at τ and estimate the probability of survival at τ + s using a survival model (e.g. Cox proportional
hazards model). We may also be interested in considering many landmark times, τ1, τ2, . . . , τL, and
developing a predictionmodel for each. To do this, we construct a prediction dataset for each landmark
time, τl , which consists of individuals still alive at τ
−
l , with administrative censoring at a prespecified
horizon, thor = τl + s. These landmark data sets are then stacked to create a “super prediction data set”
to which the landmark models are applied. We note that with the selection of multiple landmark times,
the same patient contributes to the estimation of many of the predicted residual time distributions.
It is also necessary that every subject have a value of Z at every landmark time. In practice this
may not be the case, and Z must be imputed from a model for Z, or more commonly by using the
last-observation-carried-forward (LOCF) approximation, which will be the method used in this paper.
In the most basic application of landmarking, we fit a separate model to each landmark dataset and
estimate a landmark-specific effect of the marker for predicting survival between τ and a fixed horizon
thor = τ + s. The basic landmark model is given as
h(t|τ,Z(τ ),X) = h0(t|τ ) exp{βτZ(τ ) + ζ′X} for τ ≤ t ≤ thor
where, the dependence of the baseline hazard on τ can be modeled by estimating a different baseline
hazard for each τ , that is h0(t|τ ) = h0τ (t).
As an alternative, we can apply a “super prediction model” to the stacked super dataset and allow
the regression coefficients to depend on landmark time in a smooth, parametric way, such as with a
linear or a quadratic function. This super model is defined as
h(t|τ,Z(τ ),X) = h0(t|τ ) exp{β(τ )Z(τ ) + ζ′X} for τ ≤ t ≤ thor (4)
where β(τ ) = ∑ j γ j f j (τ ), with basis functions f j (τ ) and parameters γ j . This model can be fit to the
stacked super dataset using a Cox model with stratification on τ and interaction terms Z(τ ) f j (τ ).
For estimation we maximize a pseudo-partial log-likelihood, which is the sum over the partial log-
likelihoods corresponding to the Cox models fit to each of the landmark datasets.
Instead of assuming a different baseline hazard for each τ , we can further extend this model to allow
the baseline hazard to change smoothly with landmark time. Thus, the extended super model is given
by
h(t|τ,Z(τ ),X) = h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ζ′X} for τ ≤ t ≤ thor (5)
where θ (τ ) = ∑ j η jg j (τ ), with basis functions g j (τ ) and parameters η j . In this model, g j (τ ) are now
covariates. The pseudo partial log-likelihood for this model differs slightly from the one for the model
in Eq. (4). Details are given in van Houwelingen (2007).
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This landmark super model can be generalized further. In Eq. (5), the effect ofZ depends on τ but it
does not depend on t; thus, it still has a proportional hazards structure. For some applications it may
be more appropriate to assume that the effect of Z depends on the time t − τ and to include a term
Z(τ )ω(t − τ ), where ω(s) is a smooth function of s. Thus, we can use the nonproportional hazards
extended super model given by
h(t|τ,Z(τ ),X) = h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ω(t − τ )Z(τ ) + ζ′X} for τ ≤ t ≤ thor (6)
3 Landmark Cox model construction corresponding to the illness-death
model
We now consider landmarking when Z is a binary covariate process. Under the landmark approach,
when making a prediction for a new subject at landmark time τ , we use all available information at
that landmark time. This method does not directly incorporate possible future transitions to illness.
Since landmarking uses the LOCF approximation, if the marker process covariate, Zi, is 0 at the time
of the individual’s last observation til before τ , then we set Z(τ ) = 0. Thus, it is implicitly assumed
the individual does not transition to the illness state between til and τ . Under the joint modeling
approach, when predicting for a new individual we integrate over all possible paths of an individual
through the illness-deathmodel, including the individual possibly progressing to illness state after their
last inspection but before τ . Thus, for individuals with Z(til ) = 0, if there is interest in predicting for
landmark times far later than til , joint modeling can be expected to provide a better prediction than
landmarking.
We can also demonstrate that the standard landmark approach uses a model that is not compatible
with the illness-deathmodel. Tomodel the residual time distribution in a landmarking framework with
binary Z, we consider the super landmark model in Eq. (4). If the proportional hazards assumption
in the landmark Cox model is to hold then it is necessary that β(·) in Eq. (4) does not depend on t.
We will investigate whether it is possible under the illness-death model to achieve a form for β(·) that
is independent of t. If not, then we will examine how β(τ ) can be generalized to better approximate
the correct residual time distribution.
For the purposes of our derivation, we reparameterize the hazard in Eq. (4) as follows:
h(t|τ,Z(τ ),X) = h0(t|τ ) exp
{
β(τ )(1− Z(τ )) + ζ′X} (7)
We can then define the residual time distribution for the Cox-type landmark model as surviving to
time τ + s, s > 0, given the individual was alive at landmark time τ with an illness indicator Z(τ ).
From Eq. (7), this can be written as
Pr(T ≥ τ + s|T > τ,X,Z(τ )) = exp
[
−
∫ τ+s
τ
h0(u|τ ) exp
{
β(τ )(1− Z(τ )) + ζ′X} du] (8)
3.1 Equating residual time distribution
To determine the form for β(τ ) and h0(t|τ ) in Eq. (7) that corresponds to the illness-death model,
we equate the appropriate residual time distributions for the two models. Starting with the situation
where the individual transitioned to the illness state by time τ , it is required that Eq. (8) for Z(τ ) = 1
and Eq. (3) are equal, hence
exp
{
−
∫ τ+s
τ
h0(u|τ ) exp(ζ′X) du
}
= exp
{
−
∫ τ+s
τ
λ12(u|X) du
}
⇒ h0(u|τ ) exp(ζ′X) = λ12(u|X) for all τ (9)
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Thus, the hazard for the Cox-type model in the landmark approach conditional on being in the illness
state is equivalent to the transition intensity from illness to death. Notice that it has the same form for
all landmark times.
For the situation where the individual has not yet transitioned to illness, we require that Eq. (8) for
Z(τ ) = 0 and Eq. (2) are equal, thus
exp
{
−
∫ τ+s
τ
h0(u|τ ) exp(β(τ ) + ζ′X) du
}
= Eq.(2)
⇒ β(τ ) + ζ′X = log
[
− log {Eq.(2)}∫ τ+s
τ
h0(u|τ ) du
]
Substituting in the value for h0(u|τ ) from Eq. (9):
⇒ β(τ ) + ζ′X = log [− log {Eq.(2)}]− log
{∫ τ+s
τ
λ12(u|X) du
}
(10)
which is the form for the covariate effects from the landmark Cox regression model that corresponds
to an illness-death model. Notice that the required form for β(τ ) given on the right-hand side of Eq.
(10) is quite complicated since it involves Eq. (2), which is composed of two additive terms. Also,
notice that it is dependent on both s and τ , which violates the form of the simple Cox regression model
desired for the landmark setting, that is β(·) dependent only on τ . Thus, a landmark approach with a
proportional hazards assumption is not the correct method when the true data generative model is an
illness-death model.
If λ12(u|X) = λ12,0(u) exp{α′12X}, then ζ = α12. The form of X on the right-hand side of Eq. (10) is
not linear in X and furthermore, it depends on three separate linear combinations, α′01X,α
′
02X, and
α′12X, rather than one. If there are several baseline covariates, the covariate vector can be different
for each transition, which will also not be captured by the linear form of X in the Cox model. This
suggests that the landmark Cox models should include more flexible forms for X, such as ζ(τ)′X, or
an interaction, such as φ′XZ(τ ).
We now consider special cases for the transition intensities to identify situations in which the derived
forms for the landmark Cox baseline hazard and covariate effects provide good approximations of the
residual time distribution under the illness-death model.
3.1.1 Constant and equal baseline transition intensities
Under the simplest situation of constant and equal baseline transition intensities, λ jk(t|X) =
ψ exp{α′jkX}, we obtain the following form for the baseline hazard and covariate effects under the
Cox landmark model from Eqs. (9) and (10),
h0(t|τ,X) exp(ζ′X) = ψ exp(α′12X)
β(τ ) + ζ′X = log
[
− log
(
exp
{
−ψs(eα′02X + eα′01X)
}
+ exp
(
α′01X − ψseα
′
12X
) {
1− exp {−ψs (eα′02X + eα′01X − eα′12X)}}
eα′02X + eα′01X − eα′12X
)]
− log[ψseα′12X]
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The form for the covariate effects does not resemble a structure that is implementable within a standard
Cox regression in the landmark approach. Also, β(τ ) is dependent on s and violates the form of a
simple Cox regression model in the landmark setting, which assumes that β depends only on τ .
3.1.2 Proportional hazards transition intensities
For the situation with proportional hazards transition intensities, we define the transition intensity for
j → k as λ jk(t|X) = λ jk,0(t) exp{α′X}, where λ jk,0(t) is the baseline transition intensity for the j → k
transition, such that λ02,0(t) = λ(t), λ01,0(t) = γ λ(t), λ12,0(t) = ηλ(t). We denote the cumulative
hazard (t) = ∫ t0 λ(u) du. Then from Eqs. (9) and (10), we derive
h0(t|τ,X) exp(ζ′X) = ηλ(t) exp(α′X)
β(τ ) + ζ′X = log
[
− log
(
1− η
1+ γ − η exp
{
−(1+ γ )eα′X[(τ + s) − (τ )]
}
+ γ
1+ γ − η exp
{
−ηeα′X[(τ + s) − (τ )]
})]
− log
[
ηeα
′X{(τ + s) − (τ )}
]
In this scenario, the form of the covariate effects also does not have a Cox proportional hazards
structure. Here, β(τ ) is dependent on both τ and s, unless λ(t) is a constant. As the flexibility of
the transition hazards in the illness-death model is increased, we find that the corresponding form
of the covariate effects under the landmark approach is not consistent with a Cox regression model
and depend on both τ and s. Allowing the effect of the baseline covariates to vary with transition, the
forms of the baseline hazard and covariate effects are even more complicated.
3.1.3 Short prediction horizon
Since we are typically most interested in short-term predictions, we also consider whether the Cox
model in the landmark framework approximately satisfies a proportional hazards assumption for
small time horizons of interest. Thus, we explored obtaining a simpler form of the derived residual
time distribution using theTaylor approximation. Taking the second-orderTaylor expansion of log(Eq.
(2)) and log(Eq. (3)) about s = 0, we get the following approximation of the residual time distribution
for small s
Pr(T ≥ τ + s|T > τ,X,Z(τ ) = 0)
≈ exp
{
−λ02(τ |X)s −
1
2
[
λ′02(τ |X) − λ02(τ |X)λ01(τ |X) + λ01(τ |X)λ12(τ |X)
]
s2
}
Pr(T ≥ τ + s|T > τ,X,Z(τ ) = 1) ≈ exp
{
−λ12(τ |X)s −
1
2
λ′12(τ |X)s2
}
Taking the derivative of the negative log of these equations, and denoting t = τ + s, gives us the hazard
functions
h(t|T ≥ τ,X,Z(τ ) = 0) = λ02(τ |X) − [λ′01(τ ) − λ02(τ |X)λ01(τ |X) + λ01(τ |X)λ12(τ |X)](t − τ )
h(t|T ≥ τ,X,Z(τ ) = 1) = λ12(τ |X) + λ′12(τ |X)(t − τ )
These hazards do not have the form of proportional hazards. Thus, to achieve consistency between
the illness-death model and the landmark approach we need a broader class of landmark models that
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accommodates the derived form of the hazards and contains the Cox proportional hazards model as
a special case.
Based on the derivations in this section, we conclude that Cox proportional hazards within the
landmark framework is not an appropriate model for the residual time distribution arising from an
illness-death model. We have shown that in plausible scenarios the covariate effects are a function of
both τ and s = t − τ and that the effect of baseline covariates is unlikely to bewell described by a simple,
single linear combination. For the more likely, but complicated, scenario of an illness-death model
with transition-specific baseline intensities and covariate effects, the associated h0(t|τ,X) and β(τ ) are
nonstandard and the super landmark model does not provide a good theoretical approximation of the
residual time distribution. Thus, we use a simulation study to explore the performance of extensions
within the landmark framework that accommodate nonproportional hazards, coefficient effects of Z
as a function of τ and s, more complex forms for the baseline covariate effects X, and interactions
between Z and X.
4 Simulation study
The aims of our simulation study were to compare the predictive performance of joint and landmark-
ing models in the context of illness-death data, and to evaluate whether increased landmark model
flexibility provides a better approximation to the true model.
4.1 Data generation and structuring
Five hundred simulations of n = 500 subjects were run for each scenario. Defining the states as {0:
Healthy, 1: Ill, 2: Dead}, the ages at illness onset and death without illness were generated from
λ jk(ti|Xi) =
(
ρ jk
κ jk
)(
ti
κ jk
)ρ jk−1
exp
{
α′jkXi
}
for j = 0, k = 1, 2 (11)
For the transition intensity from illness to death (1 → 2), we generate data under two different models:
(1) Markov, where the transition intensity depends only on current time and (2) semi-Markov (“clock-
reset”), where the transition depends on duration in the illness state.Under theMarkovmodel, λ12(t|X)
is given as in Eq. (11). Under the semi-Markovmodel, given the known transition timeV , the transition
intensity from illness to death is specified as λSM12 (t|X,V ) = λ12(t −V |X).
We choose the transition intensity shape and scale parameters such that λ12(t) > λ02(t) > λ01(t)
[ρ jk = 1.15 for all j → k; κ01 = 20; κ02 = 12.5; κ12 = 10]. We simulate a binary baseline covariate,
X , that has a stronger effect on death in ill subjects, with α01 = 0.5, α02 = 0.5, α12 = 2. We explored
simulating the exposure prevalence of X from 5% to 50%, but present only the results for 40% due
to the similarity of results under other percentages. We simulate right-censoring from an exponential
distribution with mean 80 and apply administrative censoring at time 20 to achieve a 15% censoring
rate. We simulate marker measurement under two patterns of observation: (1) the marker process is
continuously observed (then the exact transition time from “healthy” to “ill” is observed) and (2) the
value of the marker is observed at random inspection times. Under the scenarios where the marker, Z,
is measured at inspection times, inter-inspection times are exponentially distributed with rate 0.5.
We assume that there is interest in dynamic prediction for the first five years following baseline. Thus,
we use an equally spaced grid of landmark times from time 0 to time 5, every 0.2 years. The endpoint of
interest is death within a prediction window of s = 1, 3, 5 years from the prediction time. To structure
the data as a super dataset, we create a landmark dataset for each τ , with administrative censoring at
τ + s, and stack the landmark data sets. We also structure the data as a longitudinal dataset for the
setting with simulated inspection times. In this dataset, each patient contributes a row for each of their
inspection times (til , l = 1, . . . , ni), with administrative censoring of their event times at til + s.
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Table 1 Joint models fit in simulation study.
Model Baseline hazard Transition intensity ∀ j → k Label
Markov λ jk(t|X ) Parametric λWjk,0(t) exp{α jkX } (MM)
Semi-parametric λCoxjk,0(t) exp{α jkX } (MMCox)
Markov,V ∗ λ jk(t|X,V ∗) Parametric λWjk,0(t) exp{α jkX + γV ∗1( j = 1, k = 2)} (MSM)
Semi-parametric λCoxjk,0(t) exp{α jkX + γV ∗1( j = 1, k = 2)} (MSMCox)
Semi-Markov λ jk(t|X,V ∗) Parametric λWjk,0(t −V ∗1( j = 1, k = 2)) exp{α jkX } (SMM)
4.2 Joint models
Under the jointmodeling approach,wefit bothMarkovand semi-Markovmodels.DefiningλWjk,0(t) and
λCoxjk,0(t) as the baseline hazards of a Weibull model and Cox proportional hazards model, respectively,
we fit the parametric and semi-parametric joint models (MM), (MMCox), (MSM), (MSMCox), and
(SMM) shown in Table 1.
For (MM) we fit aMarkov illness-death model withWeibull hazard transition intensities. (MMCox)
fits the model with semi-parametric transition intensities using a Cox proportional hazards model.
These models are extended to (MSM) and (MSMCox) to account for the effect of the observed
transition time, V ∗, by including it as a covariate. For (SMM) we fit a semi-Markov illness-death
model.
Estimation is conducted using methods described in Section 2.1 with the R packages SmoothHazard
for (MM) (Touraine et al., 2014), mstate for (MMCox) and (MSMCox) (de Wreede et al., 2011), and
the function optim for the optimization of the likelihood for (MSM) and (SMM) using the quasi-
Newtonian algorithm, the code for which is available in the Supporting Information materials. We
plug in the resulting estimates (λˆ jk) into 1−Eq. (2) and 1−Eq. (3) to produce dynamic predictions of
death within s years for landmark time τl . Note that for the models that are conditional on V
∗, we
replace λ12(u|X) with λ12(u|X, v) in Eq. (2) and λ12(u|X) with λ12(u|X,V ) in Eq. (3).
4.3 Landmark models
Motivated by the derivations in Section 3 and based on the equations in Section 2.2, we fit the
landmark models (LM1), (LM2), (LM3), and (LM4) given in Table 2 to the simulated data, where
β(τ ) = β0 + β1τ + β2τ 2, θ (τ ) = θ1τ + θ2τ 2, ω(s) = ω1s + ω2s2.
For estimation, under the super dataset structuring, the τ ’s in (LM1-LM4) correspond to the chosen
grid of landmark (prediction) times. Under the longitudinal data structuring, only (LM2), (LM3), and
(LM4) apply, and the τ ’s represent the inspection times. The landmark datasets are created using the
dynpred package in R (Putter, 2015). In (LM1) we fit a simple Cox model with a different baseline
hazard for each τ . Thus, this approach can only be applied when we prespecify the landmark times
and construct the super dataset based on these landmark times. In (LM2), we still fit a simple Cox
model, but parameterize the baseline hazard to depend smoothly on τ , resulting in decreased model
flexibility but allowing us to fit the model to our longitudinal dataset. In (LM3), we propose a model
that allows for non-proportional hazards by including the covariates ω(s)Z(τ ) that are a function of
s = t − τ , to accommodate time-varying effects of our covariate process. In (LM4), we extend the Cox
model to include both β(τ ) and ω(t − τ ), since in Section 3 we showed that under the illness-death
model the form for the covariate effects for the Cox regression model in the landmark framework was
a function of both s and τ .
Under the semi-Markov model for generating data, modeling complications arise due to the change
in time scale between the transitions. Thus, for simplicity, we can incorporate the dependency of
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Table 2 Landmark models fit in simulation study.
Model Hazard Label2
LM1
h(t|τ,Z(τ ),X )
h0τ (t) exp{β(τ )Z(τ ) + ζX } (LM1)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ζX } (LM2)
h0(t) exp{θ (τ ) + β0Z(τ ) + ω(t − τ )Z(τ ) + ζX } (LM3)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ω(t − τ )Z(τ ) + ζX } (LM4)
LM,V ∗
h(t|τ,Z(τ ),X,V ∗)
h0τ (t) exp{β(τ )Z(τ ) + γV ∗Z(τ ) + ζX } (LSM1)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + γV ∗Z(τ ) + ζX } (LSM2)
h0(t) exp{θ (τ ) + β0Z(τ ) + ω(t − τ )Z(τ ) + γV ∗Z(τ ) + ζX } (LSM3)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ω(t − τ )Z(τ ) + γV ∗Z(τ ) + ζX } (LSM4)
LM, Interaction
h(t|τ,Z(τ ),X)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ζ′X + φ′XZ(τ )} (LMInt2)
h0(t) exp{θ (τ ) + β0Z(τ ) + ω(t − τ )Z(τ ) + ζ′X + φ′XZ(τ )} (LMInt3)
h0(t) exp{θ (τ ) + β(τ )Z(τ ) + ω(t − τ )Z(τ ) + ζ′X + φ′XZ(τ )} (LMInt4)
1LM: landmark model;
2 (*1): Super model; (*2): Extended super model; (*3): Extended super model, nonproportional hazards; (*4): Extended super
model, non-proportional hazards, covariate effects are a function of landmark time
transition on the observed illness time,V ∗, by including it as a covariate in the landmark models. Thus,
we modify the models (LM1–LM4) to be conditional on V ∗ with parameter γ , and fit the models
(LSM1), (LSM2), (LSM3), and (LSM4) given in Table 2.
After obtaining the estimates from these parameterizations (βˆ, θˆ , ζˆ , ωˆ, γˆ ), we compute the dynamic
predictions of death within a window of s years at the prespecified landmark times, τl , using the
following equation
Pr(T ≤ τl + s|T > τl ,Z(τl ),X,V ) = 1− exp
{
−
∫ τl+s
τl
h(u|Z(τl ),X,V, βˆ, θˆ , ωˆ, ζˆ , γˆ ) du
}
In addition to the basic scenario of a single baseline covariate, we also evaluated the performance
of landmark models when the baseline covariate vector varies by transition. We generate data with
two binary baseline covariates, X1 that has a stronger effect on death in ill subjects [α01,1 = α02,1 =
0.5, α12,1 = 2] andX2, which has no effect on death [α01,2 = 1, α02,2 = α12,2 = 0].We fit the jointmodels
(MM) and (MMCox) with the covariates X1 and X2. We modify ζX in models (LM1-LM4) to ζ
′X
where ζ = (ζ1, ζ2) and X = (X1,X2) are the parameter and baseline covariate vectors, respectively. We
also fit the additional models (LMInt2), (LMInt3), and (LMInt4), given in Table 2, that include an
interaction term with illness status and parameter vector φ = (φ1, φ2).
4.4 Performance comparison metrics
The dynamic predictions produced at the sequence of landmark times are compared to the true death
probabilities. These are obtained by using the true shape and scale parameters to get the true transition
intensities and then using numerical integration to compute the true death probability within window
s from Eqs. (2) and (3), replacing λ12(u|X) with λ12(u|V ∗,X) when generating under the semi-Markov
model. For each landmark time, we compute the bias and variance of the dynamic predictions under
the landmark approaches and joint model.
To assess the discrimination and calibration of these dynamic predictions, we use the dynamic
analogues of weighted area under the curve (AUC) and Brier score that account for censored data,
denoted AUC(τ, s) and BS(τ, s), respectively, for landmark time τ and fixed prediction window s
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(Blanche et al., 2015). Since BS depends on the cumulative incidence of death in (τ, τ + s], we used
a standardized version that results in an R2-type measure that compares how well the predictions
perform compared to a null model that assumes that all subjects have the same predicted risk of
death regardless of subject-specific information, BS0(τ, s). We denote this scaled measure R
2(τ, s) =
1− BS(τ, s)/BS0(τ, s).
To make comparisons between the different models, we compute AUC and R2 using the prediction
probabilities from the truemodels, denoted AUCTrue andR
2
True, respectively.We then report the relative
measuresAUC = AUCTrue −AUCandR2 = R2True − R2 for each of themodels, with a higher value
indicating better performance.
For cross-validation, in each simulation all of the described models were fit to a training dataset,
created by randomly selecting 4/5 of the simulated individuals. The remaining 1/5 individuals were
treated as the validation dataset, from which predicted conditional death probabilities within the
window (τ, τ + s] were obtained for those still alive at time τ .
4.5 Simulation results
Figure 2 compares the performance of the landmark model (LM1) and the joint model (MM) under
a Markov assumption with a single baseline covariate for the various prediction windows, s = 1, 3, 5.
The jointmodel performs better than the landmarkmodel across all of the predictionwindows in terms
of all of the consideredmetrics. ForZ = 0, as the prediction window increases, the bias and variance of
the joint model increases, with the reverse effect for Z = 1. There is no pattern of performance for the
landmark model (LM1) across s. However, within each prediction window, the relationship between
the performance of the different landmark models was consistent. Thus, we present the remaining
simulation results for a single prediction window, s = 3. As well, we will focus on Z = 1 for reporting
the bias and variance since the absolute bias of the models is higher than for Z = 0.
We compare the landmark and joint models in Fig. 3, which depicts the performance of the models
for Z = 1,X = 1, s = 3 for a continuously observed marker. Across all the landmark times, the joint
models perform the best in terms of bias, variance, AUC and R2, and thus give more accurate
predictions than the landmark models. Within the joint models, the semi-parametric model (MMCox)
performs almost as well as the parametric model under which the data was generated, (MM), and
both outperform the landmark models, which can have high absolute bias. In comparing the landmark
models, model (LM3), which includes time-varying effects, has the lowest variance, but has the highest
bias for early landmark times. The bias for model (LM3) decreases with increasing landmark time,
while it increases for the other landmarkmodels.Model (LM4), which incorporates both landmark and
residual time, performed similarly to the simpler landmarkmodels (LM1) and (LM2).All the landmark
models had similar AUC and R2. Thus, incorporating additional flexibility into the landmark
models did not translate into less deviation from the true predicted probabilities or substantially better
predictive performance. Due to their similar performance to (LM4), for the remaining figures we omit
the results of (LM1) and (LM2).
In Fig. 4, we compare the different methods of data structuring. When the marker is continuously
observed there is more information available than when the process is observed at inspection times,
and thus performance is better across all the metrics. Within the inspection times simulations, with the
exception of the bias for the landmark model with nonproportional hazards, the longitudinal dataset
outperformed the super dataset across all four performance metrics for all the landmark models.
Since this relationship persisted in our simulation results, and it is unlikely that markers are observed
continuously in practice, we will only present the results from the “longitudinal dataset, inspection
times marker measurement” scenarios in the rest of our comparisons.
Figure 5 shows the results from models that condition on observed illness time applied to data
generated from a Markov illness-death model. Among the joint models, parametric Markov model
(MM) and semi-parametric (MMCox) had similar performance. The joint models that condition on
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Figure 2 Simulation estimates for bias (upper-left), variance (upper-right), AUC (bottom-left),
and R2 (bottom-right) for predicted probability P(T ≤ τ + s|T > τ,Z(τ ),X ) for s = 1, 3, 5-year
predictionwindows from jointmodel (MM) and landmarkmodel (LM1), under aMarkov illness-death
model with a single baseline covariate and continuously observed marker measurement.
V ∗, (MSM) and (MSMCox), had nearly identical performance to their correspondingMarkovmodels,
and still have better performance metrics than the landmark models. The semi-Markov model (SMM)
had almost identical predictive performance to (MM), and had similar bias to the other joint models
and the lowest variance for early landmark times. The performance of the landmark models (LSM3)
and (LSM4) did not significantly change by conditioning on V ∗. Thus, when simulating under a
Markov assumption, conditioning on observed illness does not affect model performance.
In Fig. 6, we fit these same models to data generated under a semi-Markov illness-death model.
The predicted probabilities for determining the bias and variance were computed given V = 2τ/3,
for landmark time τ . The results were very similar to those in Fig. 5. The (SMM) model performed
the best, with the models that account for transition time performing marginally better than their
counterparts, but with a greater distinction than in Fig. 5. Since the gains are minimal, but existent,
when conditioning on the observed illness time in our particular situation, there is an indication that
these models will outperform the Markov models in other simulation scenarios.
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Figure 3 Simulation estimates for bias (upper-left) and variance (upper-right) for Z(τ ) = 1,X = 1,
AUC (bottom-left), andR2 (bottom-right) for predicted probabilityP(T ≤ τ + 3|T > τ,Z(τ ),X )
from the joint models (MM), (MMCox), and landmark models (LM1-LM4), under a Markov illness-
death model with a single baseline covariate and continuously observed marker measurement.
Figure 4 Simulation estimates for bias (upper-left) and variance (upper-right) for Z(τ ) = 1,X = 1,
AUC (bottom-left), andR2 (bottom-right) for predicted probabilityP(T ≤ τ + 3|T > τ,Z(τ ),X )
from the joint model (MM) and landmark models (LM3), (LM4) fit to data structured as a super
or longitudinal dataset, under a Markov illness-death model with a single baseline covariate and
continuously observed (CO) or inspection time (IT) marker measurement.
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Figure 5 Simulation estimates for bias (upper-left) and variance (upper-right) for Z(τ ) = 1,X = 1,
AUC (bottom-left), andR2 (bottom-right) for predicted probabilityP(T ≤ τ + 3|T > τ,Z(τ ),X )
from joint models (MM), (MMCox), (MSM), (MSMCox), (SMM), and landmark models (LSM3),
(LSM4) fit to data structured as a longitudinal dataset, under a Markov illness-death model with a
single baseline covariate and inspection time marker measurement.
Figure 6 Simulation estimates for bias (upper-left) and variance (upper-right) for Z(τ ) = 1,X = 1,
AUC (bottom-left), andR2 (bottom-right) for predicted probabilityP(T ≤ τ + 3|T > τ,Z(τ ),X )
from joint models (MM), (MMCox), (MSM), (MSMCox), (SMM), and landmark models (LSM3),
(LSM4) fit to data structured as a longitudinal dataset, under a semi-Markov illness-death model with
a single baseline covariate and inspection time marker measurement.
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Figure 7 Simulation estimates for bias (upper-left) and variance (upper-right) for Z(τ ) = 1,X1 =
1,X2 = 1, AUC (bottom-left), and R2 (bottom-right) for predicted probability P(T ≤ τ + 3|T >
τ,Z(τ ),X) from joint models (MM), (MMCox), and landmark models (LM3), (LM4), (LMInt3),
(LMInt4) fit to data structured as a longitudinal dataset, under a Markov illness-death model with
two baseline covariates and inspection time marker measurement.
Finally, we consider the situation where we simulate two baseline covariates with different effects on
each transition. From Fig. 7, we see that by including the interaction term XZ(τ ), the performance
of the landmark models is on par with the joint models in terms of bias. The landmark models with
the interaction term have lower variance, better R2, and similar AUC than those without the
interaction. Thus, including an interaction term in the landmark Cox model captures the effect of
baseline covariate vectors that differ by transition better than a linear function of X and provides a
much better approximation to a joint model.
Overall, based on the set of scenarios considered, the simulation results show that joint modeling
gives better performance than landmarking. The difference is generally quite small, with the exception
of bias for which the landmarking approach can have high absolute bias. The results suggest that more
general landmark models than the simplest (LM1) can improve performance and that given inspection
time data, using a longitudinal structure for the landmark dataset produces better predictions than a
super dataset. The results also indicate that misspecification of the joint model did not affect predictive
performance.
5 Applications to real data
In this section, we apply landmarking and joint models to data from two different studies that can
be modeled with an illness-death model and have information collected beyond baseline on a binary
time-dependent covariate. The large PAQUID study on cognitive aging provides interval-censored
inspection time data for transition time to the illness state and allows us to use cross-validation to
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compare the predictive performance of the methods under longitudinal and super data structures. We
also apply the models to data from a prostate cancer study with continuously observed time to clinical
failure to compare the coefficient interpretations and dynamic predictions produced under the two
approaches.
5.1 PAQUID study of cognitive aging
We evaluate the predictive abilities of landmark and joint models using data collected by the PAQUID
study. The Personnes Age´es QUID (PAQUID) Study is a large, prospective cohort study of cognitive
and physical aging (Dartigues et al., 1992). We use data from the R package SmoothHazard (Touraine
et al., 2014) on a random subset of 1000 subjects from the original study, which consisted of 3777
individuals aged 65 years and older living in southwestern France. Subjects had 10 visits over 20 years
at which they were assessed for dementia. The longitudinal dataset was created using interval-censored
observations and the approximate visit times 1, 3, 5, 8, 10, 13, 15, 17, 20 years from the initial visit.
There were 186 subjects that were diagnosed with dementia. Of the 724 deaths, 597 died without a
dementia diagnosis and 127 died after diagnosis. We model the data as an illness-death model with the
states, “alive without dementia”, “alive with dementia”, and “dead”. The baseline covariates are age
at study entry (median 74; IQR 69–79), gender (female: 58%, male: 42%), and primary school diploma
status (with diploma: 76%, without diploma: 24%).
This data represents the typical dataset for which there is interest in determining the probability
of death at a given landmark time beyond baseline of study enrollment. It involves a high-risk group
of individuals for which there is future information, that is dementia diagnosis, that can affect their
risk of death and thus must be incorporated into prediction models to produce accurate and updated
prediction probabilities. This study also involves diagnosis updates at inspection times, which allows
us to evaluate the landmark models by structuring the data as both a super dataset and a longitudinal
dataset. The large size of the dataset allows us to perform cross-validation to prevent overfitting when
assessing model performance.
We fit both landmark and joint models as in the simulation study. The subject-specific predictions
were computed at the landmark times τ = 0, 1, 3, 5, 8, 10 years for a prediction window of s = 3, 5, 7
years. The estimates for assessing predictive accuracy were obtained by performing cross-validation
based on repeated random subsampling. The data were split into 2/3 training data, to which the
models were fit, and AUC and R2 were computed for predictions from the remaining 1/3 validation
data. This procedure was repeated 500 times. We present the averaged dynamic AUC and R2 values
under the super and longitudinal data structure for s = 5, since the other prediction windows showed
similar patterns.
Fitting the model (MM) to the full data, we find that the baseline covariates of diploma status and
gender have different effects for each of the transitions. Having a diploma has a significant effect on
reducing risk of developing illness (0 → 1), and males have increased risk of death (1 → 2, 0 → 2).
Thus, we consider landmark models with an interaction term. The landmark models performed
similarly so we only present the results for models (LM3) and (LMInt3). In Fig. 8, we evaluate the
inclusion of an interaction and compare the different data structures. The model with the interaction
has better predictive performance under both structures, with the longitudinal dataset having higher
AUC at earlier time points. We investigate the performance of joint Markov and semi-Markov models
under the longitudinal data structuring in Fig. 9 and notice that the landmarking models have higher
AUC at earlier landmark times, but that joint models (MM) and (MMCox) perform consistently better
in terms of R2. The joint semi-Markov model, (SMM), performs similarly to the other joint models in
terms of both AUC and R2.
Based on this real data analysis, the predictions had similar accuracy under the different data
structures. Extensions to the landmark models that incorporate s and τ as covariates did not increase
flexibility enough to produce significant improvement in model performance. However, the inclusion
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Figure 8 PAQUID data estimates for the cross-validated prediction accuracy measure AUC (left)
and R2 (right) for predicted probability P(T ≤ τ + 5|T > τ,Z(τ ),X) from landmark models (LM3),
(LMInt3), fit to inspection time (IT) marker measurement data structured as a longitudinal or super
data set.
Figure 9 PAQUIDdata estimates for the cross-validated prediction accuracymeasure AUC (left) and
R2 (right) for predicted probability P(T ≤ τ + 5|T > τ,Z(τ ),X) for joint models (MM), (MMCox),
(SMM), and landmark models (LM3), (LMInt3), fit to data structured as a longitudinal dataset.
of an interaction between baseline covariates and Z(τ ) produces more accurate predictions. The joint
models had marginally better or equivalent performance at the landmark times than the landmark
models. The models that conditioned on transition time as a covariate did not provide a better
fit; however, the semi-Markov model (SMM) performed similarly to the Markov models, and may
outperform these models in a situation where the Markov assumption does not hold.
5.2 Prostate cancer study
We present the analysis results and dynamic predictions obtained from fitting the landmark and joint
models to data from a prostate cancer study conducted at the University of Michigan. The dataset
is composed of 745 patients with clinically localized prostate cancer who were treated with radiation
therapy.Wemeasure time from start of treatment, consideringmetastatic clinical failure (CF) as a time-
dependent binary covariate. The states of our illness-death model are “alive without clinical failure”,
“alive with clinical failure”, and “dead”. The median follow-up time was 9 years, and 52 patients
experienced clinical failure. Out of 188 deaths, 154 died before and 34 died after experiencing clinical
failure. The pretreatment prognostic factors measured at baseline are age (median 69; IQR 63–74),
log(PSA+ 1) (PSA ng/ml; median 8; IQR 5–12), Gleason score treated as a continuous covariate with
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a score of 7=“3+4” and 7.5=“4+3” (median 7; IQR 6-7.5), prostate cancer stage (T1: 57%, T2-T3:
43%), and comorbidities (0: 55%, 1–2: 37%, ≥3: 8%).
We use landmark and joint models to obtain predicted probabilities of death within 5 years for
landmark times τ = 0, 1, . . . , 8 years. We assume that the marker is continuously observed, and
structure the data as a super data set. The coefficient estimates from fitting the joint models are given in
Table 3. The parametric and semi-parametric Markov models (MM) and (MMCox), respectively, have
similar estimates for the different transitions. The (MSM) model incorporates clinical failure time as a
covariate for the 1 → 2 transition, for which the estimate is not significantly different than 0 and thus
the Markov assumption does not appear to be violated. This is further demonstrated by the estimates
for the 1 → 2 transition in (SMM), which are very similar to the estimates from the (MM) model.
The effects of the baseline covariates vary across the different transitions. Increased age significantly
increases risk of death (0 → 1, 0 → 2), higher PSA, Gleason score, and Stage T2-T3 indicate
increased risk of developing clinical failure (0 → 1), and among those with clinical failure, higher
Gleason score increases risk of death and those with 1-2 comorbidities have decreased risk of death
(1 → 2).
We present the results from fitting the landmark models in Table 4. In (LM3) we accommodate
nonproportional hazards by considering clinical failure as a time-varying covariate. The effect of
clinical failure decreases as the landmark time at which the prediction is made increases. (LM4), which
(LM2) and (LM3) are nested within, has the highest log-likelihood of the models and the lowest AIC,
indicating better fit. Since the joint models show that the baseline covariates have differential effects
on risk of death before or after clinical failure, we present the results from (LMInt4), a model with
interaction terms between clinical failure and the baseline covariates. The log-likelihood for (LMInt4)
is higher than model (LM4) and it has a lower AIC even with the penalization for including six more
covariates. Increased age, PSA, Gleason score, and number of comorbidities were all significantly
associated with increased risk of death. The only significant interaction was with comorbidities, where
those with clinical failure had a significantly decreased risk of death if they had 1–2 comborbidities
compared to no comorbidities, as was seen in the joint models. The coefficients for the baseline
covariates for the landmark models do not always properly capture the effect of the baseline covariates
on risk. For example, the coefficient for Gleason score in (LM4) is averaged over those with and
without clinical failure and thus, is much lower than the effect on the 1 → 2 transition but much
higher than the effect for the 0 → 2 transition in the joint models. As well, the effect of stage, which
is significant for the 0 → 1 transition in the joint models but has a small effect on the transitions to
death, is not properly reflected by (LMInt4), where the effect of stage on risk of death is quite high for
those who experience clinical failure.
In Fig. 10, we present the predicted probabilities from the landmark and joint models, some of
which have been omitted due to similar results, for two individuals in the dataset. The pattern of the
predictive probabilities for these specific patients is similar to that of the other patients in the dataset
with the same final clinical failure status and who experience death. Individual A has increased risk
of death due to his high PSA and number of comorbidities, thus his predicted probability of death
becomes quite high as landmark time increases and he dies before experiencing clinical failure. We see
that for this patient, the predicted probabilities from the landmark models and the semi-parametric
Markov model (MMCox) track together and the predicted probabilities for all the models are similar.
Individual B is young, but has other baseline variables that characterize him as high risk. Their effect
is particularly seen after the patient experiences clinical failure, after which his predicted probability
of death greatly increases and he dies within 2 years. The predictions from the joint models (MM) and
(SMM) are very similar both before and after clinical failure. Prior to clinical failure, the prediction
probabilities from the landmark models are lower than those from the joint models by an amount
that is not insignificant. After clinical failure, the landmark model without interactions (LM4) does
not perform well for predicting death. Thus, the landmark models require interactions between the
time-dependent binary covariate and the baseline covariates to capture the differential effects of the
covariates on the different transitions.
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Figure 10 Predicted probability of death within 5 years, P(T ≤ τ + 5|T > τ,Z(τ ),X) for two indi-
viduals in the prostate cancer dataset. Individual A (left) is 60 years old at baseline, with PSA 19.7
ng/mL, Gleason score 7.5 (“4+3”), T1 Stage, 6 comorbidities, and does not experience clinical failure
but dies 10 years from baseline. Individual B (right) is 54 years old at baseline, with PSA 16 ng/mL,
Gleason score 9, T2 Stage, zero comorbidities, and experiences clinical failure at time 3 before dying
at time 4.6 years from baseline. Black dashed line indicates time of death.
6 Discussion
Models that can incorporate updated time-dependentmarker information to revise survival predictions
are vital for identifying high-risk subjects and making timely clinical decisions. In this paper, we have
compared the theoretical justification and predictive capabilities of two such dynamic prediction
approaches: joint modeling and landmarking.
We contribute to the existing literature that compares these two approaches by investigating them
under an illness-death model. We focused on a survival model with a binary time-dependent covariate,
which is the simplest example of a joint model, to demonstrate that even in this basic situation a
Cox model in the landmark framework is not theoretically valid. With more complicated forms of
the marker process, we can expect that the discrepancies between the performance of joint models
and landmarking will be even greater, and that the inclusion of flexible forms in landmark models,
as were suggested in this paper, and better informed imputations of the marker value at landmark
times, will be even more important. In our simulation study, we demonstrate that joint modeling
produces more accurate predictions than landmarking. We simulate data under a joint model since
the landmark model provides an approach to describe the data, but is not a data-generating model.
Thus, to provide a fair comparison we also consider misspecified models within the joint modeling
framework, particularly a semi-Markovmodel and aMarkovmodelwith a nonsmooth baseline hazard.
In addition, we compared the performance of the approaches to real data from the PAQUID study
and concluded that the joint models performed marginally better than the simple landmark models.
Joint modeling and landmarking have different approaches to predicting the future for a subject.
Joint modeling achieves this by directly modeling the longitudinal variable and integrating over the
possible paths the variable might take, and thus uses the possibly strong relationship between the
longitudinal variable and the event of interest to make the prediction. Landmarking is an approach
which, in essence, obtains the empirical distribution of future event times among people similar to the
person of interest. Estimation of this empirical distribution is achieved through a descriptive model
of the residual times based on a finite number of parameters. Since the residual time distribution is
determined by the stochastic process for the longitudinal variable, landmarking does depend implicitly
on the stochastic process. The data provides information about the stochastic process of the longi-
tudinal variable, which is exploited in the joint modeling approach but ignored in the landmarking
approach. Using data from the prostate cancer study, we demonstrated that the simple landmark mod-
els do not properly capture the effects of the baseline covariates, averaging their effect on predictive
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probability over both individuals who have experienced “illness” and those who have not. The joint
models compute the predicted probability by considering all possible paths through the illness-death
model, allowing the effect of the baseline covariates to vary depending on the state in the process.
The use of more flexible landmark models and interactions between the baseline covariates and the
time-dependent “illness” indicator helps to mitigate this issue.
While the landmarking approach is appealing because it does not require specification of a longitudi-
nal model, the derivations in this paper suggest that simple forms for the landmark models are unlikely
to fit well, and that landmark models may need to include nonproportional hazards and interactions.
Thus, just as with joint models, considerable effort may be needed to obtain a good fitting model. One
difference between joint models and landmarking is in setting up the data. For joint models, the likeli-
hood is derived from the observed data and there are no choices to make. With landmarking there are
choices to make that will change the predictions, which include the number and values of the landmark
times, what time horizon to use when administratively censoring the data in the super dataset, and how
to impute Z(τ ). To avoid using LOCF, we proposed a longitudinal data structure based on inspection
times and demonstrated that in our situation it performed better than, or as well as, the super dataset
proposed by van Houwelingen and Putter (2011). Alternatively, we can specify a longitudinal model
for Z and impute a sensible value for Z(τ ) for each subject, as was done by Maziarz et al. (2016). This
approach has some similarity to the two-stage procedure of fitting a joint model in Bycott and Taylor
(1998), which is known to have small bias and be more computationally convenient than a full joint
model likelihood approach. They accomplish this by specifying the longitudinal marker process as a
random effects model plus stochastic process and using the fit of this model to obtain less variable
imputes of Z(τ ) for each subject, which are then used as covariates in a time-varying Cox model.
In our opinion, joint modeling provides a more unified and principled approach that also satisfies
the consistency criteria. It could even be enhanced by the incorporation of external information. If
the stochastic process can be well characterized, then we might expect the predictions to be more
accurate, including for longer prediction windows. In situations where the stochastic process can be
well estimated from the available data, joint modeling is likely to perform better. In situations where
it is harder to estimate, for example, sparse longitudinal data or many longitudinal variables, then the
empirical performance of landmarking might provide a good enough approximation.
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